Eledon Pharmaceuticals is a clinical stage biotechnology company with immunology expertise that is developing therapies to protect and prevent rejection of transplanted organs, as well as to treat amyotrophic lateral sclerosis (ALS). The Company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand (also called “CD154”), a well-validated biological target with broad therapeutic potential.
View Top Employees from Eledon Pharmaceuticals, Inc.Website | https://eledon.com |
Ticker | NVUS |
Revenue | $5.1 million |
Employees | 27 (19 on RocketReach) |
Founded | 2020 |
Address | 19900 MacArthur Blvd 550, Irvine, California 92612, US |
Phone | (949) 238-8090 |
Technologies |
JavaScript,
HTML,
PHP
+29 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Eledon Pharmaceuticals, Inc. employee's phone or email?
The Eledon Pharmaceuticals, Inc. annual revenue was $5.1 million in 2024.
Steve Perrin is the President and Chief Scientific Officer of Eledon Pharmaceuticals, Inc..
19 people are employed at Eledon Pharmaceuticals, Inc..
Eledon Pharmaceuticals, Inc. is based in Irvine, California.
The NAICS codes for Eledon Pharmaceuticals, Inc. are [325, 32].
The SIC codes for Eledon Pharmaceuticals, Inc. are [28, 283].